US Stem Cell Inc USRM
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Shares Outstanding
- 641.51M
- Market Cap
- $128,301.46
- Volume/Avg
- 8,900 / 288,143
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
US Stem Cell Inc is a biotechnology company engaged in the discovery and development of autologous cell therapies for the treatment of chronic and acute heart damage. Its product includes MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from a patient's body, for the purpose of improving cardiac function in chronic heart failure patients. The company's discoveries include multiple cell therapies in various stages of development that repair damaged tissues throughout the body due to injury or disease so that patients may return to a normal lifestyle.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 11
- Website
- http://www.us-stemcell.com
Valuation
|
Metric
|
USRM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
USRM
Financial Strength
|
Metric
|
USRM
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.00 |
Interest Coverage | −3.14 |
Quick Ratio
USRM
Profitability
|
Metric
|
USRM
|
|---|---|
Return on Assets (Normalized) | −2,007.84% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
USRM
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|#<$@%p | LOCK|N$$b | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|CNzl%$ | LOCK|!r%G | $83B | |||
| Moderna Inc
MRNA
| LOCK|@?w<?z< | LOCK|r^> | $80B | |||
| argenx SE ADR
ARGX
| LOCK|@&>><Mf | LOCK|VS$ | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|@M>>lP^ | LOCK|BF^ | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|%QX#^M | LOCK|qX?rb | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|<$hGw^cc | LOCK|>J<vQ | $28B | |||
| Incyte Corp
INCY
| LOCK|K!J@G%d | LOCK|%>s | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|jw@?QK | LOCK|Vc | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|mG?XYL | LOCK|<Gm | $14B |
United States